About The Max Foundation

Pat Garcia-Gonzalez

Chief Executive Officer; Global Headquarters in Seattle, USA

Erin Schwartz

Vice President of Strategic Partnerships and Communications; Global Headquarters in Seattle, USA

Inés García González

Region Head for Latin America; Latin America Regional Office in Buenos Aires, Argentina

Mei Ching Ong

Region Head for Asia Pacific; Asia Pacific Regional Office in Kuala Lumpur, Malaysia

Viji Venkatesh

Region Head for South Asia; Regional Office in Mumbai, India

Ann Kim Novakowski

Senior Program Manager; Global Headquarters in Seattle, USA

J. Michael Wrigglesworth

Director of Global Information Technology Solutions; Global Headquarters in Seattle, USA

Paula Boultbee

President of the Board

Principal at PTB Consulting LLC

Jerry Scott, CPA

Treasurer of the Board

Chartered Global Management Accountant

David Tingstad

Secretary of the Board

Beresford Booth PLLC

Pat Garcia-Gonzalez

CEO of The Max Foundation

Robert Farmer

Board Member

CML survivor and photographer

Tracey Higgins

Board Member

Edmonds Community College

Grant Rubenstein

Board Member

Rosen~Harbottle Commercial Real Estate

Medical Advisory Board

Our Medical Advisory Board includes specialists who are key opinion leaders in the field of oncology. Based all around the world, these expert physicians are formative in leading research and managing patient care at their centers of excellence. We are extremely honored to benefit from their expertise and dedication to the patients we serve.

Hematology Advisors

Michele Baccarani, MD

Head of the Institute of Hematology and Medical Oncology “L. and A. Seràgnoli”, S. Orsola at the University Hospital, Bologna, Italy

Jorge E. Cortes, MD

Professor of Medicine, Chief/CML Section, Deputy Chair, Department of Leukemia, MD Anderson Cancer Center in Houston, Texas, USA

Brian J. Druker, MD

Investigator, Howard Hughes Medical Institute, JELD-WEN Chair of Leukemia Research, USA

Francois Guilhot, MD

Head of the Department of Oncology, Hematology and Cell Therapy at The University Hospital of Poitier. President of the Chronic Myelogenous Leukemia French Group, France

Andreas Hochhaus, MD

Klinikum Mannheim der University Heidelberg in Mannheim, Germany

Timothy Hughes, MD

Hanson Institute, SA Pathology Adelaide, South Australia

Michael J. Mauro, MD

Leader, Myeloproliferative Diseases Program Member, Memorial Sloan Kettering Cancer Center Professor of Medicine, Cornell University Medical College, New York, USA

Javier Pinilla-Ibarz, MD, PhD

Associate Member and Director of Immunotherapy. Malignant Hematology Division. H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA

Jerald Radich, MD

Clinical Research Division, Member with Fred Hutchinson Cancer Research Center and Professor of Medicine at University of Washington, USA

Delphine Rea, MD, PhD

Doctor of Medicine and Sciences, Service d’Hématologie adulte, Hôpital Saint-Louis, France

Neil P. Shah, MD, PhD

Edward S. Ageno Distinguished Professor in Hematology/Oncology Leader, Hematopoietic Malignancies Program Helen Diller Family Comprehensive Cancer Center University of California, San Francisco, USA

Moshe Talpaz, MD

Assoc. Director for Translational Research, The University of Michigan Health Systems, Ann Arbor, Michigan, USA

Oncology Advisors

Matías Chacón, MD

Medical Oncologist at the Instituto Médico Alexander Fleming in Buenos Aires, Argentina

George D. Demetri, MD

Director of the Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute Associate Professor of Medicine, Harvard Medical School, USA

Peter Reichardt, MD

Head of the Department of Interdisciplinary Oncology Director of the Sarcoma Center Berlin-Brandenburg Director of the Cancer Center Berlin-Buch at HELIOS Klinikum Berlin-Buch in Berlin, Germany

Jonathan Trent, MD

Co-Director, Musculosketal Center Director, Sarcoma Medical Research Program Professor of Medicine at Sylvester Cancer Center in Miami, Florida, USA

Carolyn Blasdel, FNP-BC

Tacoma, USA

R. Banks Bourne, MBA

Chief Executive Officer, Bourne Partners, Charlotte, North Carolina, USA

Rhonda Curry

Interim VP, Communications at Fred Hutchinson Cancer Research Center, Seattle, USA

Gilberto de Lima Lopes, Jr., MD, MBA, FAMS

Associate Professor of Clinical Medicine, Medical Director for International Programs and Associate Director of Global Oncology at Sylvester Comprehensive Cancer Center at the University of Miami, Miami, USA

Michele Galen, J.D.

Communications Consulting and Transition Coach, Boston, USA

Teresa Guillien, MPA

Managing Program Director Resource Media and Faculty in the Nonprofit Management Certificate Program at the University of Washington, USA

William E. Heisel, Journalism BA

Director of Global Engagement, The Institute of Health Metrics and Evaluation (IHME) at the University of Washington, USA

Michael Mandola, PhD

Global Medical Director, HQ Medical Lung, Immuno-Oncology, Bristol-Myers Squibb

 Jerald Radich, MD

Clinical Research Division, Member with Fred Hutchinson Cancer Research Center and Professor of Medicine at University of Washington, USA

Carlos Rodriguez-Galindo, MD

Executive Vice-President, Director of International Outreach Program; Chair, International Pediatric Research, St. Jude Children’s Research Hospital; Memphis, TN, USA.

Lawrence N. Shulman, MD

Deputy Director for Clinical Services, Director Center for Global Cancer Medicine, Abramson Cancer Center at University of Pennsylvania, USA

Andy Stergachis, PhD, BPharm

Professor of Pharmacy and Global Health, Associate Dean of School of Pharmacy, and Director of the Global Medicines Program, University of Washington (UW)

Kristofer Rogers

Director of Marketing & Fundraising at Cancer Council Australia, Sydney, Australia